... NEW YORK May 15 /- American OrientalBioen... Our thoughts are with the many victims of China's earthquake and wea...About American Oriental Bioengineering Inc. ...American Oriental Bioengineering Inc. is a pharmaceutical companydedi...

NEW YORK, May 15 /PRNewswire-FirstCall/ -- American Oriental
Bioengineering, Inc. (NYSE: AOB), a pharmaceutical company dedicated to
improving health through the development, manufacture and commercialization
of a broad range of prescription and over the counter ("OTC") products in
China, today released the following statement regarding the earthquake in
China:

"Our thoughts are with the many victims of China's earthquake and we
are thankful to report that none of our staff was hurt in the tragic
events. Our manufacturing, production and overall operations were not
impacted by the earthquake and we do not anticipate any damage-related
impact to our sales in the second quarter," stated Mr. Tony Liu, Chairman
and Chief Executive Officer of American Oriental Bioengineering.

About American Oriental Bioengineering Inc.

American Oriental Bioengineering Inc. is a pharmaceutical company
dedicated to improving health through the development, manufacture and
commercialization of a broad range of prescription and over the counter
products in China. For more information, visit http://www.bioaobo.com.

Statements made in this press release are forward-looking and are made
pursuant to the safe harbor provisions of the Securities Litigation Reform
Act of 1995. Such statements involve risks and uncertainties that may cause
actual results to differ materially from those set forth in these
statements. The economic, competitive, governmental, technological and
other factors identified in the Company's filings with the Securities and
Exchange Commission, including the Form 10-K for the year ended December
31, 2007, may cause actual results or events to differ materially from
those described in the forward looking statements in this press release.
The Company undertakes no obligation to publicly update or revise any
forward-looking statements, whether because of new information, future
events, or otherwise.

(Date:12/8/2016)... ALAMEDA, Calif. , Dec. 8, 2016 Singulex, ... Single Molecule Counting technology, entered into a license and ... in serving science. The agreement provides Singulex access to ... Europe is used to diagnose ... the United States to aid in assessing ...